Help your IBS symptoms with a low FODMAP diet
FODMAP what? Have you heard? It’s the new dietary approach for the bloating and belly cramps seen with irritable bowel syndrome (IBS).
IBS affects one in seven Americans. It’s a gut condition which affects the flora in the bowels and causes abdominal pain, cramping, diarrhea or constipation, bloating, gas and overall discomfort and misery. It can be life changing and debilitating; jeans and Spanx don’t stand a chance!
IBS has been treated in the past with drugs like Zelnorm that are now off the market, probiotics and prebiotics (that are expensive but all the rage), bulking agents and laxatives that fill the aisles ...
Source: Kevin, M.D. - Medical Weblog - February 28, 2017 Category: Journals (General) Authors: < a href="http://www.kevinmd.com/blog/post-author/katherine-freeman" rel="tag" > Katherine Freeman, MD < /a > Tags: Conditions GI Source Type: blogs
Undoctored: An Excerpt
Here’s an excerpt from my new book, Undoctored: Why Healthcare Has Failed You and How You Can Become Smarter Than Your Doctor. In Undoctored, I take the lessons learned from the worldwide Wheat Belly experience and put them to work in a new program that helps reverse hundreds of health conditions–because conventional healthcare has abdicated its responsibility and is no longer about reclaiming health.
The Undoctored movement will get you and your family back on track, having cracked the code on health, slenderness, and higher levels of life performance. The book will be released May 9th, 2017, but is available ...
Source: Wheat Belly Blog - February 25, 2017 Category: Cardiology Authors: Dr. Davis Tags: News & Updates gluten grains health Inflammation recipes undoctored Weight Loss wheat belly Source Type: blogs
A positive visit with a patient with chronic pain
We have two ears and one mouth so we can listen twice as much as we speak,” said Epictetus. It’s clear that the Greek philosopher wasn’t a physician in 21st century America. If you watch doctors — and many researchers do — they speak more than listen.
Studies have shown that doctors interrupt or redirect patients within the first half minute of talking. I’m just as guilty. I fear that if I don’t quickly home in on the top priorities, the patient will ramble on ad infinitum.
How long, I’ve sometimes wondered, would my patients actually talk if I didn’t say anything at all? According to a group of Swiss res...
Source: Kevin, M.D. - Medical Weblog - February 20, 2017 Category: Journals (General) Authors: < a href="http://www.kevinmd.com/blog/post-author/danielle-ofri" rel="tag" > Danielle Ofri, MD, PhD < /a > Tags: Physician Primary care Source Type: blogs
Genome surgery with CRISPR-Cas9 to prevent blindness
It is estimated that almost one in every ten people over 65 has its own signs of age-related macular degeneration (AMD), and its prevalence is likely to increase as a result of the aging population. AMD is a form of blindness, common in Caucasians, which in turn causes distorted vision and blind spots. Researchers at the Center for Genome Architectural, within the Institute for Basic Science (IBS) report the use of CRISPR-Cas9 in performing “gene surgery” in the coating of tissue that supports the particular retina of living mice. Released in Genome Research, this study combines basic research and mouse design ...
Source: My Irritable Bowel Syndrome Story - February 16, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Why male immune cells are from Mars and female cells are usually from Venus
Michigan State University researchers are the first to uncover reasons why a specific type of immune cellular acts very differently in females compared to males while under stress, resulting in women being more susceptible to certain diseases.
Related Posts:Immune cell’s role in intestinal movement may lead to…Group suppresses oxidative stress and neuronal death…Connection between genes that make cells deaf to messages…Drug shows surprising efficacy as therapy for chronic…Researchers create a multifunctional endoscopeThe post Why male immune cells are from Mars and female cells are usually...
Source: My Irritable Bowel Syndrome Story - February 7, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Opioid Induced Hyperalgesia Prevented by Buprenorphine?
“Buprenorphine is a kappa receptor antagonist. For these reasons, buprenorphine might be unique in its ability to treat chronic pain and possibly OIH.”
The opioid crisis has been fueled by the use of opioids to treat chronic pain. Practice patterns have changed, but doctors are still criticized for their roles in the overuse of opioids. I’ve sat through community ‘heroin forums’ (sometimes on stage) as sheriffs, politicians, and ‘recovered addicts’ firmly pointed fingers at health professionals. I, meanwhile, kept my finger under the table, but had the thought that some of the people pointing ...
Source: Suboxone Talk Zone - February 5, 2017 Category: Addiction Authors: Jeffrey Junig MD PhD Tags: Acute Pain Buprenorphine Chronic pain Suboxone treatment buprenorphine treats chronic pain chronic pain treatment opioid induced hyperalgesia opioid pain relief pain vs. addiction Source Type: blogs
Food and antibiotics may change microorganisms within gut, causing IBS
A recent review of research suggests that changes to the microorganisms (microbiota) in the gastrointestinal (GI) tract may be a cause of irritable bowel syndrome (IBS). The review article is published in the American Diary of Physiology—Gastrointestinal and Liver Physiology.
Related Posts:Combining epigenetic therapies with immunotherapies likely…IBS and bloating: When the gut microbiota gets out of…Evaluation suggests yoga beneficial in irritable bowel…Non-celiac wheat sensitivity may be an allergy5 fast facts about norovirusThe post Food and antibiotics may change microorganisms within gut, causin...
Source: My Irritable Bowel Syndrome Story - January 27, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Tucatinib (ONT-380) progressing in pivotal demo against HER2+ breast cancer
Stage 1 clinical trial data published this week in the journal Clinical Malignancy Research show early promise from the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The particular 50 women treated had advanced despite a median 5 earlier treatment regimens. Twenty-seven percent of the heavily pretreated patients saw scientific benefit from the drug, with at least “stable disease” at 24 or more days after the start of treatment. These data led to two subsequent Phase Ib studies, resulting in tucatinib earning FDA fast-track status and the enlargement of this study on...
Source: My Irritable Bowel Syndrome Story - January 11, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
IRRITABLE BOWEL SYNDROME affects women ’ s quality of life more than mens
Double work and a higher embarrassment factor can lead to the quality of life being affected more among women than men by irritable bowel syndrome (IBS), a very common gastrointestinal disease. Even with the same level of actual pain and other symptoms, women’s recognized quality of life is worse than the mens, according to new research.
Related Posts:IBS and bloating: When the gut microbiota gets out of…New drug to help common bowel conditionIs Ibs Considered A Physical Disability?What is Irritable Bowel SyndromeAnxiety and Depression Thanks To IBSThe post IRRITABLE BOWEL SYNDROME affects women’s qualit...
Source: My Irritable Bowel Syndrome Story - January 9, 2017 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Rifaximin effective for repeat treatment of IRRITABLE BOWEL SYNDROME with diarrhea
(HealthDay)—Repeat treatment with the nonsystemic antibiotic rifaximin works well in patients with relapsing symptoms of diarrhea-predominant irritable bowel syndrome (IBS-D), according to a study published in the December issue of Gastroenterology.
Related Posts:Evaluation suggests yoga beneficial in irritable bowel…Eluxadoline eases pain and diarrhea for a few with IBSTreatment for IBS With Severe ConstipationRifimax to Treat IBSLow FODMAP diet cuts irritable bowel syndrome symptomsThe post Rifaximin effective for repeat treatment of IRRITABLE BOWEL SYNDROME with diarrhea appeared first on My Irritable Bowel Syn...
Source: My Irritable Bowel Syndrome Story - December 27, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Making health decisions in the face of uncertainty: Let your values be your guide
Follow me on Twitter @DavidAScales
My sister texted me recently about my nine-year-old niece. She’d been experiencing joint pain so saw her pediatrician for a check-up. They did some blood tests, which were all normal except one.
“Should we be worried?” my sister asked.
“I’m no pediatrician, but I’d let it go,” I said. “It’s like seeing a cloud in the sky and asking me if I’m concerned about a hurricane.” Should we worry about and investigate every cloud when most don’t end up being a passing storm, let alone a hurricane?
Many patients are like my sister, looking for certainty that everything is nor...
Source: Harvard Health Blog - December 21, 2016 Category: Consumer Health News Authors: David Scales, MPhil, MD, PhD Tags: Health Health care Managing your health care Source Type: blogs
Type of psychotherapy matters in treatment of irritable bowel syndrome
Worldwide, roughly one adult in 10 is suffering from a painful and sometimes debilitating situation called irritable bowel syndrome, or IBS.
Related Posts:Anxiety and Depression Thanks To IBSConnection between genes that make cells deaf to messages…Treatment for IBS With Severe ConstipationPsychotherapies have long-term benefit for those suffering…Headache, tension headaches and irritable bowel syndrome…The post Type of psychotherapy matters in treatment of irritable bowel syndrome appeared first on My Irritable Bowel Syndrome Story. (Source: My Irritable Bowel Syndrome Story)
Source: My Irritable Bowel Syndrome Story - December 12, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
The antibody that normalizes tumor vessels
An important parcel must be sent to the correct place. It is so important it can be a question of life or even death. However , uneven streets and missing railings risk to bring it off the road and leave it undelivered. This is not the trailer of a dilemma, but what happens to anti-cancer medicines traveling towards the tumor area, but unable to reach it because of dysfunctional blood vessels. The Center for Vascular Study, within the Institute for Basic Science (IBS) discovered that their antisepsis antibody ABTAA (Ang2-Binding and Tie2-Activating Antibody) also reduces tumor volume plus improves the delivery of anti-canc...
Source: My Irritable Bowel Syndrome Story - December 12, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
Nivolumab with chemotherapy improves response, survival in AML study patients
The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled reaction rates and improved overall success in patients with acute myeloid leukemia (AML), according to preliminary findings by researchers at The University of Texas MD Anderson Cancer Center.
Related Posts:CTCA at Western Regional Medical Center advances combinationImmunotherapy with live bacterium improves response rate in…Adjuvant chemotherapy improves overall survival in patients…Drug shows surprising efficacy as therapy for chronic…Experts propose new staging for HPV-related oropharyngeal…The post ...
Source: My Irritable Bowel Syndrome Story - December 5, 2016 Category: Gastroenterology Authors: Ken Tags: IBS News Source Type: blogs
G-Tech Medical: Next-Generation Diagnostic for Gastrointestinal Disorders
Gastrointestinal disorders are the cause of significant morbidity in the United States, resulting in over $50B in healthcare expenditures by some estimates. Diagnosis of these disorders relies on largely anatomic evaluation with radiographic imaging and endoscopy. These tests poorly assess functional pathology. G-Tech Medical, a company based at the Fogarty Institute for Innovation and headed by Steve Axelrod, PhD, promises to deliver GutCheck, a non-invasive diagnostic patch that evaluates functional characteristics of the gastrointestinal system by measuring electrical activity.
The technology was first tested in...
Source: Medgadget - November 28, 2016 Category: Medical Equipment Authors: William Kethman Tags: GI Source Type: blogs
